Stem cell start­up Thym­mune lands $37M from Biden's ARPA-H for im­mune-re­ju­ve­nat­ing ther­a­pies

The Biden ad­min­is­tra­tion is award­ing up to $37 mil­lion to Thym­mune Ther­a­peu­tics, the Ad­vanced Re­search Projects Agency for Health (ARPA-H) an­nounced Thurs­day. The biotech start­up us­es stem cells to de­vel­op thy­mus-re­ju­ve­nat­ing ther­a­pies.

Thym­mune’s new fund­ing comes amid a busy week for ARPA-H, a new re­search agency that the Biden ad­min­is­tra­tion es­tab­lished last year to fund big swings at bio­med­i­cine’s tough­est prob­lems.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER